|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 38/18 | |||
| A61K 39/395 | |||
| A61K 31/713 | |||
| A61K 31/7088 | |||
| C07K 16/28 | |||
| A61P 9/00 | |||
| A61P 9/04 | |||
| A61P 43/00 | |||
| C07K 16/22 |
| (11) | Patento numeris | 2739645 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12820719.8 |
| Europos patento paraiškos padavimo data | 2012-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-06-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/049018 |
| Data | 2012-07-31 |
| (87) | Numeris | WO 2013/019805 |
| Data | 2013-02-07 |
| (30) | Numeris | Data | Šalis |
| 201161513930 P | 2011-08-01 | US | |
| 201161578477 P | 2011-12-21 | US |
| (72) |
KAPUR, Navin, K., US
KARAS, Richard, H., US
|
| (73) |
Tufts Medical Center, Inc.,
750 Washington Street, Boston, MA 02111,
US
|
| (54) | ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS |
| ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS |